<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03517189</url>
  </required_header>
  <id_info>
    <org_study_id>63054016.1.0000.5505</org_study_id>
    <nct_id>NCT03517189</nct_id>
  </id_info>
  <brief_title>Hemodynamic Changes During Displacement of the Heart in the Aorta No-touch Off-pump Coronary Artery Bypass Surgery</brief_title>
  <official_title>Hemodynamic Changes During Displacement of the Heart in the Aorta No-touch Off-pump Coronary Artery Bypass Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: Aorta no-touch off-pump coronary artery bypass surgery (OPCAB) has been the
      recommended technique for treatment of patients with high-risk of neurological damage or
      stroke. However, the displacement of the heart to achieve suitable exposure for graft
      construction elicits hemodynamic changes, potentially requiring conversion to on-pump.
      Objective: The aim of this study is to evaluate the sequential changes of hemodynamic
      parameters in patients that undergo aorta no-touch OPCAB. Method: Patients that undergo aorta
      no-touch OPCAB will be evaluated. The FloTrac / PreSep / Vigileo ™ (Edwards Lifesciences)
      system will be used to continuously record heart rate (HR), mean arterial pressure (DBP),
      central venous pressure (CVP), continuous cardiac index, systolic volume , systolic volume
      variation (VVS) and central venous oxygen saturation (ScvO2). The parameters will be
      evaluated 5 min before, during and 5 min after each anastomosis (left anterior
      descending-LAD, posterior descending PD, marginal-OM and diagonal-Dg). Postoperative lactate
      will also be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2017</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in heart rate</measure>
    <time_frame>The parameters will be assessed 5 min before, during and 5 min after each anastomosis (left anterior descending-LAD, posterior descending-PD, marginal-OM and diagonal-Dg).</time_frame>
    <description>By the FloTrac/PreSep/Vigileo™ system (Edwards Lifesciences), assessing the change in heart rate during procedures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in mean arterial blood pressure</measure>
    <time_frame>The parameters will be assessed 5 min before, during and 5 min after each anastomosis (left anterior descending-LAD, posterior descending-PD, marginal-OM and diagonal-Dg).</time_frame>
    <description>By the FloTrac/PreSep/Vigileo™ system (Edwards Lifesciences), assessing the change in mean arterial blood pressure during procedures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in central venous pressure</measure>
    <time_frame>The parameters will be assessed 5 min before, during and 5 min after each anastomosis (left anterior descending-LAD, posterior descending-PD, marginal-OM and diagonal-Dg).</time_frame>
    <description>By the FloTrac/PreSep/Vigileo™ system (Edwards Lifesciences), assessing the change in central venous pressure during procedures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in continuous cardiac index</measure>
    <time_frame>The parameters will be assessed 5 min before, during and 5 min after each anastomosis (left anterior descending-LAD, posterior descending-PD, marginal-OM and diagonal-Dg).</time_frame>
    <description>By the FloTrac/PreSep/Vigileo™ system (Edwards Lifesciences), assessing the change in continuouns cardiac index during procedures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in stroke volume</measure>
    <time_frame>The parameters will be assessed 5 min before, during and 5 min after each anastomosis (left anterior descending-LAD, posterior descending-PD, marginal-OM and diagonal-Dg).</time_frame>
    <description>By the FloTrac/PreSep/Vigileo™ system (Edwards Lifesciences), assessing the change in stroke volume during procedures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in central venous oxygen saturation</measure>
    <time_frame>The parameters will be assessed 5 min before, during and 5 min after each anastomosis (left anterior descending-LAD, posterior descending-PD, marginal-OM and diagonal-Dg).</time_frame>
    <description>By the FloTrac /PreSep/Vigileo™ system (Edwards Lifesciences), assessing the change in central venous oxygen saturation during procedures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate lactate levels</measure>
    <time_frame>Immediate postoperative period, at the admission on the intensive care unit</time_frame>
    <description>Evaluation of the lactate levels in the immediate postoperative</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cardiac Surgery</condition>
  <condition>Aorta No-touch</condition>
  <arm_group>
    <arm_group_label>Aorta no-touch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aorta no-touch off-pump coronary artery bypass surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Aorta no-touch</intervention_name>
    <description>Participants will be submitted to aorta no-touch off-pump coronary artery bypass surgery.</description>
    <arm_group_label>Aorta no-touch</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with a diagnosis of coronary artery disease with indication of myocardial
             revascularization surgery

        Exclusion Criteria:

          -  patients will be excluded if they presented clinically significant preoperative
             hepatic or renal dysfunction, thrombocytopenia, coagulopathy, or uncontrolled
             arrhythmia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Federal University of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>04023062</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Solange Guizilini, PhD</last_name>
      <phone>+5511982887753</phone>
      <email>s_guizilini@yahoo.com.br</email>
    </contact>
    <investigator>
      <last_name>Walter J. Gomes, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2018</study_first_submitted>
  <study_first_submitted_qc>May 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2018</study_first_posted>
  <last_update_submitted>May 4, 2018</last_update_submitted>
  <last_update_submitted_qc>May 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Solange Guizilini</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

